National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

efaproxiral
A synthetic small molecule with radiosensitizing activity. Efaproxiral increases oxygen levels in hypoxic tumor tissues by binding non-covalently to the hemoglobin tetramer and decreasing hemoglobin-oxygen binding affinity. Increasing tumor oxygenation reduces tumor radioresistance. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:RSR13



Previous:Edecrin, edotecarin, edrecolomab, EF5, efalizumab
Next:efavirenz, Effexor, eflornithine, eflornithine hydrochloride ointment, Efudex

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov